Longevity Health Holdings, Inc. Cash Flow Conversion Efficiency
Longevity Health Holdings, Inc. cash flow conversion efficiency. Based on the latest financial reports, Longevity Health Holdings, Inc. (XAGE) has a cash flow conversion efficiency ratio of 0.070x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-485.29K) by net assets ($-6.89 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Longevity Health Holdings, Inc. (2021–2025)
Cash flow conversion efficiency of Longevity Health Holdings, Inc. from 2021 to 2025. This chart illustrates how Longevity Health Holdings, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View XAGE stock price for real-time trading data and today's change.
Longevity Health Holdings, Inc. Cash Flow Conversion Ratio Explained
Longevity Health Holdings, Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Longevity Health Holdings, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Longevity Health Holdings, Inc. ranked by their cash flow conversion efficiency. Also see Longevity Health Holdings, Inc. (XAGE) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PETREL RESOURCES (PQ4.SG)
STU:PQ4
|
0.088x |
|
Ontrak Inc
NASDAQ:OTRK
|
-0.586x |
|
BEBO Health SA
PA:MLBBO
|
N/A |
|
Ariana Resources plc
LSE:AAU
|
-0.024x |
|
Storage Drop Storage Technologies Ltd
TA:STRG
|
0.581x |
|
GCL Global Holdings Ltd Warrants
NASDAQ:GCLWW
|
-0.003x |
|
ROBUS GROUP AS EO -60
F:LH2
|
N/A |
|
Pebble Beach Systems Group PLC
LSE:PEB
|
0.350x |
Annual Cash Flow Conversion Efficiency for Longevity Health Holdings, Inc. (2021–2025)
The table below shows the annual cash flow conversion efficiency of Longevity Health Holdings, Inc. from 2021 to 2025. Review XAGE FCF to total liabilities ratio to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-5.87 Million | $-3.33 Million | 0.567x | -39.07% |
| 2024-12-31 | $-4.71 Million | $-4.39 Million | 0.931x | +376.10% |
| 2023-12-31 | $24.75 Million | $-8.35 Million | -0.337x | -434.49% |
| 2022-12-31 | $-37.79 Million | $-3.81 Million | 0.101x | +153.45% |
| 2021-12-31 | $-29.58 Million | $-1.18 Million | 0.040x | -- |
About Longevity Health Holdings, Inc.
Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth fa… Read more